Journal article · 2024
Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response
Accounts of Chemical Research, 57(6), 905–918 · Published 28 February 2024 · DOI 10.1021/acs.accounts.3c00771
In brief
“Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response” is a 2024 journal article by Caiyan Zhao and 5 co-authors, published in Accounts of Chemical Research. OpenAlex counts 92 citations as of 21 November 2026, which puts it in the top 1% of works published in 2024 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 92
- Most cited in
- 2025 (43)
- Field-weighted impact
- 12.13
- References
- 68
- Authors
- 6
Abstract
Conspectus Cancer vaccines have shown tremendous potential in preventing and treating cancer by providing immunogenic antigens to initiate specific tumor immune responses. An in situ vaccine prepared from an autologous tumor can mobilize a patient’s own tumor cell lysate as a reservoir of specific antigens, thus triggering a broad immune response and diverse antitumor immunity… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Zhao, C., Wang, C., Shan, W., Wang, Z., Chen, X. S., & Deng, H. (2024). Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response. Accounts of Chemical Research, 57(6), 905–918. https://doi.org/10.1021/acs.accounts.3c00771
MLA 9
Zhao, Caiyan, et al. “Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response.” Accounts of Chemical Research, vol. 57, no. 6, 2024, pp. 905–918. https://doi.org/10.1021/acs.accounts.3c00771.
Chicago
Zhao, Caiyan, Changrong Wang, Wenbo Shan, Zhongliang Wang, Xiaoyuan Shawn Chen, and Hongzhang Deng. 2024. “Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response.” Accounts of Chemical Research 57 (6): 905–918. https://doi.org/10.1021/acs.accounts.3c00771.
Harvard
Zhao, C. et al. (2024) ‘Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response’, Accounts of Chemical Research, 57(6), pp. 905–918. doi:10.1021/acs.accounts.3c00771.
IEEE
C. Zhao, C. Wang, W. Shan, Z. Wang, X. S. Chen, and H. Deng, “Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response,” Accounts of Chemical Research, vol. 57, no. 6, pp. 905–918, 2024, doi: 10.1021/acs.accounts.3c00771.
BibTeX
@article{zhao2024nanomedicines,
title = {{Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response}},
author = {Zhao, Caiyan and Wang, Changrong and Shan, Wenbo and Wang, Zhongliang and Chen, Xiaoyuan Shawn and Deng, Hongzhang},
journal = {Accounts of Chemical Research},
year = {2024},
volume = {57},
number = {6},
pages = {905--918},
doi = {10.1021/acs.accounts.3c00771},
url = {https://doi.org/10.1021/acs.accounts.3c00771}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 11 | |
| 2025 | 43 | |
| 2026 | 38 |
Its field-weighted citation impact is 12.13: it has been cited 12.13 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- nanomedicine
- immunosuppressive tumor microenvironment
- tumor-associated antigens
- damage-associated molecular patterns
- antigen presentation
- adjuvant effect
- cancer metabolism
- cancer immunotherapy
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Zhao, C., Wang, C., Shan, W., Wang, Z., Chen, X. S., & Deng, H. (2024). Nanomedicines for an Enhanced Immunogenic Cell Death-Based In Situ Cancer Vaccination Response. Accounts of Chemical Research, 57(6), 905–918. https://doi.org/10.1021/acs.accounts.3c00771
How many times has this paper been cited?
92 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Caiyan Zhao, Changrong Wang, Wenbo Shan, Zhongliang Wang, Xiaoyuan Shawn Chen, Hongzhang Deng.
What is the DOI of this paper?
10.1021/acs.accounts.3c00771, permanently at https://doi.org/10.1021/acs.accounts.3c00771. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.